Mark Wilterding - Edwards Lifesciences VP Relations

All Insiders Germany . 
Stock . Edwards Lifesciences . Stakeholders . Insider . Mark Wilterding
EWL Stock  EUR 68.26  0.46  0.68%   

Insider

Mark Wilterding is VP Relations of Edwards Lifesciences
Phone949 250 2500
Webhttps://www.edwards.com

Edwards Lifesciences Management Efficiency

The company has return on total asset (ROA) of 0.1334 % which means that it generated a profit of $0.1334 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2614 %, meaning that it generated $0.2614 on every $100 dollars invested by stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities.
Edwards Lifesciences has accumulated 596.3 M in total debt with debt to equity ratio (D/E) of 19.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Edwards Lifesciences has a current ratio of 3.59, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Edwards Lifesciences until it has trouble settling it off, either with new capital or with free cash flow. So, Edwards Lifesciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Edwards Lifesciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Edwards to invest in growth at high rates of return. When we think about Edwards Lifesciences' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Nir PatelGameStop Corp
N/A
BASc MBAHochschild Mining plc
52
Chris BradfordGamma Communications plc
N/A
Isac BursteinHochschild Mining plc
56
Chris WadeGamma Communications plc
N/A
William CastellGamma Communications plc
N/A
Matt FrancisGameStop Corp
N/A
Eduardo LandinHochschild Mining plc
N/A
Andy MorrisGamma Communications plc
52
Phil StubbsGamma Communications plc
N/A
Mark RobinsonGameStop Corp
N/A
Ignacio BustamanteHochschild Mining plc
51
Jose PalmaHochschild Mining plc
56
Eduardo VillarHochschild Mining plc
50
Charles GordonHochschild Mining plc
N/A
James BellGameStop Corp
55
Diana SaadehJajehGameStop Corp
53
Robert LloydGameStop Corp
61
Matthew FurlongGameStop Corp
43
Raj BhasinHochschild Mining plc
N/A
Marc SummeyGameStop Corp
N/A
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12800 people. Edwards Lifesciences (EWL) is traded on Frankfurt Exchange in Germany and employs 17,300 people.

Management Performance

Return On Equity0.26
Return On Asset0.13

Edwards Lifesciences Leadership Team

Elected by the shareholders, the Edwards Lifesciences' board of directors comprises two types of representatives: Edwards Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Edwards. The board's role is to monitor Edwards Lifesciences' management team and ensure that shareholders' interests are well served. Edwards Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Edwards Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Ullem, Co CFO
Larry Wood, Co Replacement
Mark Wilterding, VP Relations
Donald Bobo, Corp Devel
Todd Brinton, Co Officer
Arnold Pinkston, Corp Counsel
Dirksen Lehman, Co Affairs
Michael Mussallem, Chairman CEO
JeanLuc Lemercier, Middle Europe
Christine McCauley, Co HR

Edwards Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Edwards Lifesciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.26
Return On Asset0.13
Profit Margin0.28 %
Operating Margin0.33 %
Current Valuation43.48 B
Shares Outstanding608.31 M
Shares Owned By Insiders0.82 %
Shares Owned By Institutions86.92 %
Price To Earning45.19 X
Price To Book7.49 X

Currently Active Assets on Macroaxis

ESRTEmpire State Realty
CCitigroup
CCitigroup
GOOGAlphabet Inc Class C
DDDupont De Nemours

Other Information on Investing in Edwards Stock

Edwards Lifesciences financial ratios help investors to determine whether Edwards Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Edwards with respect to the benefits of owning Edwards Lifesciences security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY